GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » Capex-to-Operating-Income

Star Combo Pharma (ASX:S66) Capex-to-Operating-Income : 10.63 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Star Combo Pharma Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Star Combo Pharma's Capital Expenditure for the six months ended in Dec. 2024 was A$-0.17 Mil. Its Operating Income for the six months ended in Dec. 2024 was A$0.02 Mil.

Hence, Star Combo Pharma's Capex-to-Operating-Income for the six months ended in Dec. 2024 was 10.63.

Star Combo Pharma Capex-to-Operating-Income Historical Data

The historical data trend for Star Combo Pharma's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Combo Pharma Capex-to-Operating-Income Chart

Star Combo Pharma Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - 3.28 -

Star Combo Pharma Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.13 4.00 - 10.63

Competitive Comparison of Star Combo Pharma's Capex-to-Operating-Income

For the Household & Personal Products subindustry, Star Combo Pharma's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Star Combo Pharma's Capex-to-Operating-Income Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Star Combo Pharma's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Star Combo Pharma's Capex-to-Operating-Income falls into.


;
;

Star Combo Pharma Capex-to-Operating-Income Calculation

Star Combo Pharma's Capex-to-Operating-Income for the fiscal year that ended in Jun. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-1.442) / -0.096
=N/A

Star Combo Pharma's Capex-to-Operating-Income for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.17) / 0.016
=10.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Combo Pharma  (ASX:S66) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Star Combo Pharma Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Star Combo Pharma's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Combo Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » Capex-to-Operating-Income
Comparable Companies
ASX:ZNO ASX:PTL ASX:MCP ASX:AN1 ASX:SKN PG XPAR:OR LSE:ULVR CL BOM:500696 KMB KVUE LSE:RKT XTER:HEN3 XTER:BEI CHD EL TSE:4452 OSTO:ESSITY B CLX
Traded in Other Exchanges
N/A
Address
171 - 177 Woodpark Road, Smithfield, Sydney, NSW, AUS, 2164
Website
https://www.starcombo.com.au
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.

Star Combo Pharma Headlines

No Headlines